City Hill Ventures — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

OncoMyx TherapeuticsDec 2021

BiotechPhoenix, US

Douglas Grant McFadden, Ph.D.(Director)Steven J. Potts, Ph.D.(President and Chief Executive Officer)Ting Xiao(Director)Jason Rushton(Director)Kanad Das, Ph.D.(Director)Michael G. Wood(Executive Officer)

Co-investorsB Capital Group Boehringer Ingelheim Venture Fund Delos Capital Korea Investment Partners Lumira Ventures LYZZ Capital +1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.